Cel-Sci (CVM) vs Elutia (ELUT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Elutia (ELUT) has outperformed Cel-Sci (CVM) over the past year, losing 6.5% versus a loss of 79.1%. Over five years, ELUT leads with a -85.0% price change compared with -99.3% for CVM. Elutia is the larger company by market cap ($36.3 million vs $35.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVM | ELUT |
|---|---|---|
| Share price | $2.01 | $0.82 |
| Market cap | $35.30M | $36.32M |
| 1-day change | -5.79% | -0.01% |
| YTD return | -59.51% | +18.34% |
| 1-year return | -79.12% | -6.49% |
| 5-year return | -99.32% | -84.95% |
| EPS (TTM) | $-1.69 | $-0.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.39 | $1.39 |
| 52-week low | $0.89 | $0.50 |
| Distance from 52-week high | -80.68% | -40.79% |
| Average volume | 241.50K | 184.45K |
| Shares outstanding | 17.59M | 44.29M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ELUT has outperformed CVM by 72.6 percentage points over the past year.
CVM vs ELUT FAQ
Which is bigger, Cel-Sci or Elutia?
Elutia (ELUT) is larger, with a market capitalization of $36.32M compared with $35.30M for Cel-Sci (CVM).
Which stock has performed better over the past year, CVM or ELUT?
ELUT returned -6.49% over the past 12 months, compared with -79.12% for CVM (price return, excluding dividends). Past performance does not predict future results.
Are Cel-Sci and Elutia in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.